Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation

Abstract There is a strong desire to develop docetaxel (DTX) formulation with good therapeutic effectiveness in view of serious adverse reactions of the commercial formulation of DTX (Taxotere®). In this study, a redox-responsive DTX-vitamin E prodrug was successfully formulated into liposomes with the drug loading of 4.14% ± 0.10%. Compared with DTX liposomes, the DTX prodrug liposomes (DPLs) showed good stability for 30-d shelf life and during dilution with different media. In vitro antitumor activity of DPLs on human prostatic carcinoma PC-3 cells and human lung cancer A549 cells was evaluated using cytotoxicity and apoptosis assays. In spite of a decrease in in vitro antitumor activity, the in vivo pharmacokinetic study reveals that DPLs exhibit significantly longer DTX plasma half-life (t1/2, 1.38-fold) and higher bioavailability (AUC0−t, 14.49-fold) compared with DTX liposomes. The antitumor activity of DPLs to the A549 tumor xenograft model showed selective accumulation in tumor tissue, significant inhibition the growth of the tumors and a much lower toxicity as seen in body weight loss, compared with DTX-Solution. Taken together, the results showed that DPLs is a promising strategy for DTX antitumor delivery.

[1]  S. Yılmaz,et al.  The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy , 2016, AAPS PharmSciTech.

[2]  A. Abbasi,et al.  Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies. , 2015, Colloids and surfaces. B, Biointerfaces.

[3]  F. Liu,et al.  Molecular-matched materials for anticancer drug delivery and imaging. , 2015, Nanomedicine.

[4]  Ying Jiang,et al.  The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation. , 2015, International journal of pharmaceutics.

[5]  Li Li,et al.  Poly(ethylene glycol)-block-poly(ε-caprolactone)–and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery , 2015, International journal of nanomedicine.

[6]  Zhifu Yang,et al.  Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation. , 2015, Molecular pharmaceutics.

[7]  T. Tsai,et al.  Dual‐effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment , 2015, Lasers in surgery and medicine.

[8]  Jin Sun,et al.  Star-shape redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol-lysine-di-tocopherol succinate for tumor-triggering intracellular doxorubicin rapid release: head-to-head comparison. , 2014, Macromolecular bioscience.

[9]  F. Liu,et al.  Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines , 2014, Nano letters.

[10]  S. Jon,et al.  Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. DeSimone,et al.  Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. , 2014, Nano letters.

[12]  Daehee Kim,et al.  A novel aqueous parenteral formulation of docetaxel using prodrugs. , 2014, International journal of pharmaceutics.

[13]  C. Macosko,et al.  Silicate Esters of Paclitaxel and Docetaxel: Synthesis, Hydrophobicity, Hydrolytic Stability, Cytotoxicity, and Prodrug Potential , 2014, Journal of medicinal chemistry.

[14]  Shirui Mao,et al.  Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. , 2013, ACS nano.

[15]  Qin Chen,et al.  Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. , 2012, Biomaterials.

[16]  G. Zhai,et al.  N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin , 2012, Journal of liposome research.

[17]  K. Letchford,et al.  Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. , 2012, Molecular pharmaceutics.

[18]  Neeraj Kumar,et al.  Amphotericin-B-loaded polymersomes formulation (PAMBO) based on (PEG)₃-PLA copolymers: an in vivo evaluation in a murine model. , 2011, Molecular pharmaceutics.

[19]  N. Zhang,et al.  Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery. , 2010, Journal of biomedical nanotechnology.

[20]  Norbert Maurer,et al.  Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Ulbrich,et al.  HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. , 2010, Molecular pharmaceutics.

[22]  T. Ganesh.  Improved biochemical strategies for targeted delivery of taxoids. , 2007, Bioorganic & medicinal chemistry.

[23]  J. White,et al.  Rapid separation of low molecular weight solutes from liposomes without dilution. , 1978, Analytical biochemistry.